Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹808.85
Day range
₹800.00 - ₹827.00
Year range
₹511.00 - ₹930.00
Market cap
42.59B INR
Avg Volume
7.31K
P/E ratio
55.02
Dividend yield
2.24%
Primary exchange
NSE
Market news
.DJI
0.81%
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.57B | 16.32% |
Operating expense | 514.50M | 16.75% |
Net income | 241.70M | 39.71% |
Net profit margin | 15.40 | 20.03% |
Earnings per share | 4.51 | 38.77% |
EBITDA | 430.32M | 31.50% |
Effective tax rate | 28.64% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.80B | 28.48% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 5.28B | — |
Shares outstanding | 53.47M | — |
Price to book | 7.71 | — |
Return on assets | — | — |
Return on capital | 13.72% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 241.70M | 39.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,693